Rhythm Biosciences (ASX:RHY) Short-Term Capital Lease Obligation : A$0.00 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Rhythm Biosciences Short-Term Capital Lease Obligation?

Rhythm Biosciences's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was A$0.00 Mil.

Rhythm Biosciences's quarterly Short-Term Capital Lease Obligation increased from Dec. 2023 (A$0.00 Mil) to Jun. 2024 (A$0.08 Mil) but then declined from Jun. 2024 (A$0.08 Mil) to Dec. 2024 (A$0.00 Mil).

Rhythm Biosciences's annual Short-Term Capital Lease Obligation declined from Jun. 2022 (A$0.09 Mil) to Jun. 2023 (A$0.09 Mil) and declined from Jun. 2023 (A$0.09 Mil) to Jun. 2024 (A$0.08 Mil).

Rhythm Biosciences Short-Term Capital Lease Obligation Historical Data

The historical data trend for Rhythm Biosciences's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Biosciences Short-Term Capital Lease Obligation Chart

Rhythm Biosciences Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.04

0.09

0.08

Rhythm Biosciences Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial										-	0.09	-	0.08	-

Rhythm Biosciences Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Rhythm Biosciences Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Rhythm Biosciences's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhythm Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rhythm Biosciences Ltd (ASX:RHY) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 Flemington Road, Bio21 Institute, Parkville, Melbourne, VIC, AUS, 3010

Website

https://www.rhythmbio.com

Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. The company operates predominantly in one business and geographical segment which is the research and development of biosciences in Australia.

Rhythm Biosciences Headlines

No Headlines